Patent · US Active

Method for treating Philadelphia-negative myeloproliferative syndromes

US8217079B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

ITALFARMACO SPA · IT

Inventors

Paolo Mascagni · Sesto San Giovanni, IT
Carmine D'urzo · Savona, IT
Josee Golay · Bergamo, IT

Key dates

Filing date	Mar 26, 2010
Grant date	Jul 10, 2012
Priority date	—
Expiry date	Aug 27, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Method for treating Philadelphia-negative myeloproliferative syndromes in a patient in need of such treatment, by administering to the patient diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof, in combination with N-hydroxyurea.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.